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Based on the observation that wild-type Kaposi’s sarcoma-associated herpesvirus (KSHV) DNA can be
detected in the oral cavity of healthy, immunocompetent individuals, we hypothesized that epithelial cells could
be infected in vitro by wild-type (WT) KSHV isolated from immunocompetent individuals. Primary oral
epithelial (P-EPI) cells and telomerase-immortalized oral epithelial cells were generated from human gingival
tissue and were then infected in vitro with WT KSHV isolated from throat wash samples. Markers of lytic and
latent KSHV infection were detected in cultures by 24 h postinfection by immunofluorescence confocal
microscopic assays. The infectivity of the WT and BCBL virus was blocked by neutralizing antibodies against
KSHV gB. The presence of KSHV DNA in these cells was confirmed by real-time PCR amplification of different
regions of the viral genome. The significant in vitro viral replication that had occurred was inhibited by
ganciclovir and by neutralizing antibodies against gB. When infected cultures were examined by scanning
electron microscopy, thousands of KSHV particles were clearly visible across the surfaces of P-EPI cells. The
detection of enveloped particles indicated that the infectious cycle had proceeded through assembly and egress.
We thus demonstrated that oral WT KSHV isolated from immunocompetent individuals was able to infect and
replicate in vitro in a relevant primary cell type. Furthermore, our results provide compelling evidence for
KSHV transmission within infected oral epithelial cells derived from healthy, immunocompetent populations.
Kaposi’s sarcoma-associated herpesvirus (KSHV; also called
human herpesvirus 8 [HHV-8]) is the etiologic agent of Kapo-
si’s sarcoma (KS) (12) and peripheral effusion lymphoma
(PEL) (10). The human herpesviruses are generally ubiquitous
among human populations, are generally shed in the oral cav-
ity, and are primarily transmitted via the salivary route. How-
ever, current serological tests for KSHV have determined that
the seroprevalence within the general U.S. population is low,
suggesting that, unlike the other human herpesviruses (with
the exception of herpes simplex virus type 2 [HSV-2]), KSHV
is not ubiquitous among healthy human populations.
The primary mode of KSHV transmission remains unre-
solved, as extensive evidence exists for both sexual (8, 25, 30,
31) and oral (5, 29, 34) transmission routes in immunosup-
pressed individuals. However, recent epidemiology studies sug-
gested that oral transmission of KSHV does occur among
healthy populations (14, 15). Complicating the transmission
issue, the identities of the cell types harboring KSHV in vivo in
the oral cavity and producing the virus detected in saliva are
not known. Endothelial cells are the primary infected cells in
KS lesions (7). Recently, KSHV antigens were detected in oral
epithelial cells of an early KS lesion (44). In addition, the
ability of the virus to infect primary human keratinocytes has
also been demonstrated (3, 9). Based on the above evidence,
we hypothesized that the wild-type (WT) isolates present in the
oral cavity of healthy, HIV-negative individuals might differ in
tropism from PEL-associated laboratory KSHV strains. We
therefore employed an infection protocol initially described by
Vieira and colleagues (42) to characterize in vitro WT KSHV
infections of cultured epithelial cells.
We also hypothesized that KSHV infections are likely
spread between healthy individuals by virus shed into saliva. To
test this hypothesis, we isolated WT KSHV from throat wash
(TW) samples of healthy, immunocompetent donors and used
it as an inoculum to infect primary oral epithelial (P-EPI) cells
and telomerase-immortalized oral epithelial (T-EPI) cells de-
rived from human gingival tissue. Our results provide compel-
ling evidence that KSHV is an opportunistic pathogen that
replicates in oral epithelial cells.
MATERIALS AND METHODS
Cells and media. Human melanoma (MeWo) cells were cultured in Eagle’s
minimal essential medium (GIBCO-BRL) containing 10% fetal bovine serum
(FBS) (Sigma) and supplemented with nonessential amino acids (GIBCO-BRL),
penicillin, streptomycin, and L-glutamine (GIBCO-BRL) as previously described
(23). A293T cells, a simian virus 40 (SV40) T-cell-transformed clone of the
HEK293 line (22), were a gift from Lishan Su (University of North Carolina,
Chapel Hill) and were cultured and transfected as previously described (18).
BJAB and BCBL1 cell lines were cultured in RPMI 1640 medium supplemented
with 10% FBS and containing penicillin, streptomycin, sodium pyruvate, and
L-glutamine (GIBCO-BRL). P-EPI cells were generated by a modified protocol
initially described by Oda and Watson (32). Fragments of gingival tissue removed
after dental extractions from healthy, HIV-negative individuals and obtained
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with informed consent were washed four times in keratinocyte-SFM medium
(KGM) containing bovine pituitary extract and epidermal growth factor supple-
ments furnished by the manufacturer (Invitrogen) as well as penicillin, strepto-
mycin, sodium pyruvate, and L-glutamine (GIBCO-BRL). For prevention of the
growth of bacterial and fungal contaminants, the KGM was further supple-
mented with Normocin and Fungin at the concentrations recommended by the
manufacturer (Invivogen, Inc.). The fragments were floated in a 1:1 solution of
KGM and 0.25% trypsin (GIBCO-BRL) in a small culture dish for 10 to 14 h at
4°C. The epithelial and fibroblast layers were then separated, and the epithelial
layers were placed in a 15-ml conical tube with 5 ml of phosphate-buffered saline
(PBS) containing 2% FBS (Sigma) and shaken vigorously for several minutes.
The remains of the epithelial fragments were removed from the tube, and the
shaking was repeated with fresh PBS–2% FBS in another tube. The remains of
the tissue were removed, and the two cell suspensions were pooled and pelleted by
centrifugation at 400  g for 5 min at 4°C. The cell pellet was washed once in KGM,
resuspended in 2 ml of fresh KGM, plated in a 60-mm-diameter culture dish, and
incubated at 36°C in 5% CO2. One volume of fresh, warm medium was added every
48 h, and the medium was changed completely after 5 to 6 days of culture. The cells
began to adhere to the dish after 4 to 5 days in culture, and they became 50%
confluent after an additional 10 to 15 days. P-EPI monolayers were split 1:3 when
they were 40 to 60% confluent. All cells stained positive for epidermal growth factor
receptor, indicating their epithelial origin.
Transduction. P-EPI cells from passages 1 and 2 were immortalized by trans-
duction with a retrovirus vector containing the human telomerase gene (h-tert)
(6). P-EPI cells (5  105) were seeded onto a 60-mm-diameter culture dish and
allowed to adhere overnight. The KGM was removed, and 2 ml of fresh, cell-free
h-tert-containing retrovirus supernatant from A293T cells at 48 h posttransfection
was added to the P-EPI monolayer. After 3 h of incubation at 37°C, 2 ml of fresh
KGM was added to the culture dish. After overnight incubation, the medium was
changed, with fresh KGM added to the monolayers. The medium was changed every
24 to 48 h, and these T-EPI cells were split 1:3 every 4 to 7 days.
Virus isolation. TW samples in 10 ml of sterile PBS were obtained with
informed consent from nine different healthy, HIV-negative, KS-negative indi-
viduals for use in infections. Wild-type KSHV was isolated from these samples as
previously described (42). Nine different donors were employed for at least three
independent infection experiments with each cell type. Briefly, after incubation with
1 mM dithiothreitol at ambient temperature, the oral cells were removed from the
samples by centrifugation. The cell pellets were frozen for DNA isolation and/or
spotted onto slides for confocal immunofluorescence assays (IFAs), described be-
low. The TW fluid supernatant was filtered and underwent high-speed ultracentrif-
ugation at 4°C in an SWTi 41 rotor (Beckman Instruments, Inc., Palo Alto, Calif.).
The supernatant was discarded, and the virus pellets were resuspended in 50 to 100
l of PBS. Similarly, the replication of latently infected KSHV in BCBL1 cells was
induced by a 2-h incubation with 25 ng of tetradecanoyl phorbol acetate (TPA)/ml,
after which the medium was replaced with fresh RPMI. Cells were cultured for an
additional 48 to 72 h, and KSHV virus was isolated by high-speed centrifugation of
the filtered culture supernatant as described above. The supernatant from unin-
fected BJAB cells served as a negative control.
Conditions of infection. Cell monolayers were trypsinized, washed, resus-
pended in fresh culture medium, mixed with the resuspended WT virus, BCBL
virus, or BJAB culture medium (mock/endogenous infection), and plated in
eight-well chamber slides (Falcon) or 35-mm-diameter well culture plates at a
concentration of 2.5  105 cells/ml. At various hours postinfection (hpi), the
monolayers were further processed for IFA or DNA isolation, as described
below. The replication of KSHV in T-EPI and A293T cells was blocked by the
addition of 2.5 mg of ganciclovir (Roche Laboratories, Inc.)/ml or 10 mg of
acyclovir (Sigma)/ml to the culture medium at the time of infection. The infec-
tion of T-EPI and A293T cells was blocked by preincubation of the resuspended
virus pellet with 60 g of neutralizing anti-gB antibody or the UK-218 control
antibody (a gift from B. Chandran, University of Kansas, Kansas City)/ml as
described previously (1).
IFAs. The detection of KSHV antigens in infected cell monolayers was per-
formed as previously described (44). Briefly, monolayers were fixed in 1:1 meth-
anol-acetone, washed in PBS, and blocked overnight at 4°C with 20% normal
goat serum (NGS) in PBS. Cells were incubated overnight at 4°C with the
following primary antibodies diluted in 20% NGS: a mouse monoclonal antibody
against the lytic infection-associated viral glycoprotein K8.1 (11), purified rabbit
polyclonal antibodies against the viral glycoprotein gB (a gift from B. Chandran,
University of Kansas) (1), rabbit polyclonal antibodies against KSHV latency-
associated nuclear antigen (LANA) (a gift from D. Ganem, University of Cali-
fornia, San Francisco), or a murine isotype control antibody or rat monoclonal
antibody against KSHV LANA (27) (Advanced Biotechnologies, Inc., Columbia,
Md.). A murine immunoglobulin G1 isotype control antibody (CalTag, Inc.) was
used to optimize KSHV K8.1 primary antibody concentrations. Lastly, cells were
washed, stained with goat anti-mouse antibody (K8.1), goat anti-rat secondary
antibody (LANA) conjugated to AlexaFluor 488, or goat anti-rabbit secondary
antibody (gB) conjugated to AlexaFluor 547 and ToPro-3 DNA stain (Molecular
Probes, Inc.) for 1 h at ambient temperature, and analyzed by confocal micros-
copy on an Olympus FV500 microscope. Oropharyngeal cells isolated from TW
samples were smeared onto slides and stained as described above, except that
they were blocked in 20% NGS for 2 to 5 days at 4°C prior to staining to
minimize background signals from oral flora.
Imaging by SEM. P-EPI-3 passage 3 monolayers were infected with BCBL1-
derived or WT virus as described above and seeded onto eight-well chambered
borosilicate coverslips (Nalge Nunc International). At 48 hpi, the monolayers
were washed with PBS, fixed in PBS containing 1% glutaraldehyde, and shipped
overnight on ice to the University of Iowa Central Microscopy Research Facility.
High-resolution scanning electron microscopy (SEM) was performed by methods
specifically optimized for the visualization of herpesvirus particles on the surfaces
of infected cells (24, 33, 39).
DNA isolation and PCR amplification. Infected cell monolayers were removed
from the plastic culture surface by incubation with trypsin-EDTA (Gibco) for 5
min, which ensured that viral particles associated with the outer cell surfaces
were removed. DNAs were isolated from TW cells and from infected cell mono-
layers by using a DNEasy kit protocol recommended by the manufacturer (Qia-
gen, Inc., Valencia, Calif.). Cellular DNAs were employed for nested PCR
amplifications to detect KSHV ORF 26 DNA. Briefly, 300 ng of cellular DNA
was used as a template for the first-round PCR with an outer primer pair in a
50-l reaction volume, and 5 l of the first-round reaction was used as template
DNA for the second round with an inner primer pair. DNAs from uninfected
BJAB and latently infected BCBL1 cells were used as negative and positive
controls, respectively. Three hundred nanograms of cellular DNA was also em-
ployed for real-time PCR detection of KSHV ORF 73, using primer and probe
sequences (Qiagen Operon Technologies, Inc.) that were previously described by
Dittmer et al. (17). Real-time PCR detection of lytic K8.1 from 150 ng of cDNA
was also employed, using primer sequences (Lineberger Cancer Center Nucleic
Acid Core Facility, University of North Carolina) that were previously described
by Fakhari and Dittmer (19). Real-Time PCRs were performed by using an ABI
Prism 7000 sequence detection system, with Taqman Universal PCR master mix
and No AmpEraseUNG (Applied Biosystems, Foster City, Calif.). DNA from
latently infected BCBL1 cells served as a positive control. DNA from uninfected
BJAB cells and reactions run in the absence of added DNA served as negative
controls. The cellular genes -actin and glyceraldehyde-6-phosphate dehydroge-
nase were amplified to ensure the quality of the cDNAs and to serve as loading
controls (data not shown). Analysis of the data was performed with the associ-
ated Prism 7000 software (Applied Biosystems), and relative KSHV DNA copy
numbers were calculated by employing a standard curve of induced BCBL1 DNA
serially diluted 10-fold in DG75 cell DNA. The undiluted copy number was
arbitrarily set at 107 copies/300 ng of DNA based on quantitative results with
other primer-probe sets. The PCR products generated by real-time PCR from
cDNAs were electrophoresed in a 2% agarose gel and subsequently visualized by
Southern blot hybridization with a 32P-labeled probe internal to the primer pair,
as previously described (19).
RNA isolation and reverse transcription-PCR amplification. RNAs from in-
fected and uninfected cells were isolated with an RNeasy kit as directed by the
manufacturer (Qiagen, Inc.). Contaminating DNAs were removed by use of a
DNAfree kit (Ambion). cDNA was generated by using 0.1 M RNA, a 0.5 mM
concentration of each deoxynucleoside triphosphate, and 25 nM random-6 oligonu-
cleotides (Qiagen, Inc.) in a 20-l reaction volume. The reaction was heated to 65°C
for 5 min and cooled to 4°C for 2 min. One microliter of Super Script II (Gibco), 4
l of 5 SSII buffer, and 10 mM dithiothreitol were then added to the reaction,
which was heated for 1 h at 42°C and 70°C for 15 min and then quantified. Duplicate
reactions were performed without the addition of enzyme to generate reverse tran-
scription-negative controls. The cDNA was subsequently employed for PCR ampli-
fication of lytic and latent KSHV gene sequences as described above.
RESULTS
Endogenous WT KSHV isolated from primary oral epithe-
lial cells. For characterization of the state of the WT virus
infections in the donor oral cavities, oropharyngeal cells iso-
lated from TW samples employed as sources of WT KSHV
were analyzed for the expression of latent and lytic viral pro-
teins (Fig. 1A, panel 2). Bacterial DNA was often detected on
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the oropharyngeal cells isolated from TW samples (Fig. 1A,
panel 2, lower right). In addition, relative amounts of viral
DNA isolated from oropharyngeal cells of several donors were
compared to that detected in BCBL1 cells (Fig. 1C). Both
LANA and the K8.1 viral glycoprotein associated with lytic
infections were detected in 3 to 15% of the cells isolated from
different TW donors, and the numbers of antigen-containing
cells remained similar in consecutive samples taken at intervals
of 10 to 30 min and 6 days to several weeks from the same
donor (data not shown). The KSHV ORF 26 gene was ampli-
fied from DNA isolated from the oropharyngeal TW cells (Fig.
1B, lanes 1 to 7), with one exception (lane 7). KSHV ORF 26
was also detected in consecutive TW samples taken from the
same donor at 30-min intervals on two separate occasions (Fig.
1B, lanes 1 and 2 and lanes 3 and 4), demonstrating that the
presence of WT KSHV in cells of the oral cavity was not
unusual for this individual. Donor 5 was seropositive, donor 6
is known to be seronegative, and the status of the remaining
donors is unknown. None of the donors were men who have
sex with men. In addition, real-time PCR amplification of the
ORF 73 gene from these DNA samples was detected above the
threshold level at cycle numbers 31 to 39 and with relative copy
numbers that ranged from 3 to 1,500 per 300 ng of DNA, while
the BJAB negative control remained below the threshold (Fig.
1C). Interestingly, the signal from the known seropositive do-
nor sample crossed the threshold after 31 cycles, which was
several logs higher than the other donors (Fig. 1C).
The detection of WT KSHV antigens in all donor samples
suggested that the P-EPI cells and the T-EPI cells might also
have been infected with endogenous WT KSHV. An analysis
of P-EPI-2 and T-EPI-1 cultures at different passages con-
firmed the presence of endogenous WT KSHV in both cul-
tures, which were generated from tissues of two different HIV-
negative individuals (Fig. 1A, panels 2 and 3, and Fig. 1B, lanes
8 and 12). The P-EPI-2 cells remained positive for KSHV
LANA and K8.1 antigens through passage 7 (Fig. 1B), at which
time the culture senesced, although the percentage of positive
cells decreased with each passage (data not shown). By passage
10, the immortalized T-EPI-1 cells were negative for KSHV
DNA and KSHV antigen expression by real-time PCR ampli-
fication and IFA, respectively (see Fig. 3C; also data not
shown), indicating that the endogenous virus did not persist for
long in primary oral epithelial cultures. Nevertheless, our re-
sults demonstrated the presence of endogenous WT KSHV in
primary epithelial cell cultures and the ability of this virus to
express both latent and lytic proteins in cells isolated from the
oral cavities of immunocompetent, HIV-negative individuals.
Differences in replication characteristics in epithelial cell
lines. The replication of KSHV isolated from latently infected
PEL cell lines such as BCBL1 induced to replicate by activa-
tion with phorbol esters has been well characterized in many
different cell types (3, 4, 37). For determination of the extent to
which WT KSHV could infect transformed epithelial cell lines,
a melanoma cell line (MeWo) and the SV40 T-antigen-trans-
formed A293T cell line were infected with WT virus isolated
from TW samples. A recent report demonstrating that KSHV
efficiently utilizes the 31 integrin for entry (2) suggested that
in vitro infection might be more efficient if the cells were in the
process of adhering, rather than already adherent, when ex-
posed to the virus. Therefore, the cells were trypsinized just
prior to infection with WT KSHV and BCBL1-derived virus.
Both WT and BCBL viruses were able to establish a latent
infection in MeWo cells by 24 hpi, as demonstrated by IFA
detection of the LANA protein in these cells (Fig. 2A, left
panel). Lytic infection, defined by IFA detection of the K8.1
glycoprotein, appeared to be rare, as it was only detected twice
in the BCBL virus-infected cells (Fig. 2A, right panel). Viral
DNA was readily detectable by PCR amplification of the ORF
26 gene at 48 hpi (Fig. 2B). Latent infection was still detectable
by IFA at 48 hpi, but not at 72 hpi (Table 1; data not shown).
Real-time PCR analyses of cellular DNA at various time points
postinfection suggested that the KSHV infection was transient
in MeWo cells; the amount of viral DNA decreased steadily
during the first 96 hpi (Fig. 2C). The BCBL1-derived virus was
more prevalent at the early times postinfection (perhaps due to
an occasional lytic event, as illustrated in Fig. 2A), and re-
mained detectable longer by both real-time and conventional
PCR (Fig. 2C; data not shown).
Surprisingly, the infection of A293T cells was primarily lytic
in nature; LANA was not expressed at detectable levels with
either the anti-rat monoclonal antibody or the anti-rabbit poly-
clonal antibody beyond 12 hpi (Table 1). Interestingly, the WT
virus replicated more efficiently in these cells than the BCBL
virus, as demonstrated by the consistent observation of increas-
ing foci of K8.1 glycoprotein expression observed in WT-in-
fected monolayers over time (Fig. 2D; Table 1). Indeed, the
WT virus appeared to mediate cytopathic effects in these cells,
specifically cell membrane fusion formation at 48 to 96 hpi,
which created large K8.1 glycoprotein-positive foci containing
multiple nuclei (Fig. 2D). Collectively, these results suggested
that interesting phenotypic differences existed between WT
KSHV isolated from the oral cavity and the PEL-associated
BCBL virus. Interestingly, tonsillar B lymphocytes were also
successfully infected with KSHV (data not shown).
Replication differences between TW KSHV and BCBL1-de-
rived KSHV in primary oral epithelial cells. To test the ability
of WT KSHV and the PEL-associated BCBL1 virus to repli-
cate in a primary oral epithelial cell model, we inoculated
P-EPI and T-EPI cells with WT and BCBL1-derived viruses
(Fig. 3). Infections of each cell type were repeated at least
three times with WT KSHV virus isolated from TW samples of
different donors, with similar results. In both P-EPI and T-EPI
TABLE 1. IFA detection of lytic and latent WT KSHV infection of
epithelial cells
Cell type Virus
Detection of lytic virus/detection of latent virus at
indicated hpia
12 24 48 72 96
MeWo BCBL / / / / /
WT / / / / /
A293T BCBL ND / / / /
WT ND / / / /
P-EPI BCBL ND / / / /
WT ND / / / /
T-EPI BCBL ND / / / /
WT ND / / / /
a Lytic virus was measured by counting the K8.1-positive cells in the mono-
layer. , not detectable; , 1%; , 1 to 2%; , 3 to 5%; , 6 to 10%;
, 	10%. Latent virus was measured by counting the LANA-positive cells
in the monolayer. , not detectable; , 1%; , 1 to 5%; , 6 to 10%. ND,
not done.
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FIG. 1. Detection of endogenous KSHV present in oropharyngeal cells of WT KSHV donors and early-passage primary epithelial cell cultures.
(A) Immunofluorescent confocal microscopic detection of KSHV antigens. Monolayers were fixed and incubated with isotype antibody or an
antibody against KSHV LANA or glycoprotein K8.1. Secondary antibodies conjugated to AlexaFluor 488 were used to detect the primary antibody
bound to the KSHV protein, and ToPro-3 dye was used to detect nuclear DNA. Panel 1, antigen-positive controls (TPA-induced BCBL1 cells).
Upper photos show the Alexa 488 fluorescence, and lower photos show the nuclei stained with ToPro-3. Panel 2, donor oropharyngeal cells. Upper
photos show the Alexa 488 fluorescence, and lower photos show the nuclei stained with ToPro-3. Panel 3, P-EPI-2 passage 4. Upper photos show
the Alexa 488 fluorescence, and lower photos show the nuclei stained with ToPro-3 merged with the Alexa 488 fluorescence and the bright-field
images. Panel 4, T-EPI 1 passage 4. Upper photos show the Alexa 488 fluorescence, and lower photos show the nuclei stained with ToPro-3 merged
with the Alexa 488 fluorescence and the bright-field images. (B) Detection of KSHV ORF 26 by conventional PCR. DNAs from uninfected BJAB
and latently infected BCBL1 cells were used as negative and positive controls, respectively. Lanes 1 to 7, oropharyngeal DNA isolated from donor
TW samples; lane 8, P-EPI-2 passage 7 cell DNA; lane 9, BCBL1 cell DNA; lane 10, BJAB cell DNA; lane 11, no template DNA; lane 12, T-EPI
1 passage 6 DNA (this sample was run on another gel, but the PCRs were performed in the same experiment as the rest of the lanes). (C) Real-time
PCR amplification plot of KSHV ORF 73 in donor oropharyngeal cell DNA. DNAs isolated from TW donor oropharyngeal cells from one
KSHV-seropositive (sero) donor and six other donors (TW donors) were used as templates for real-time PCR detection of KSHV ORF 73 DNA.
DNA isolated from uninfected BJAB and latently infected BCBL1 cells served as negative and positive controls, respectively. KSHV DNA copy
numbers relative to a standard curve of 10-fold serially diluted BCBL1 DNA are shown in parentheses. n. det., not detectable.
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cell cultures, the WT KSHV isolates replicated more efficiently
than the BCBL1-derived virus over a 96-h interval, and two
late lytic antigens, gpK8.1 and gB, could be visualized in these
cells, although more lytic than latent antigen was consistently
observed (Fig. 3A to C). Furthermore, this WT virus could be
induced to replicate with the addition of phorbol esters, such
as TPA and sodium butyrate (data not shown). The results of
these experiments are summarized in Table 1. Relative differ-
ences in replication rates between the viruses were also de-
tected by real-time PCR amplification of lytic and latent genes
from cDNA or DNA isolated from cells at different times
postinfection (Fig. 3D and E). Cell monolayers were
trypsinized and washed prior to DNA isolation to remove any
remaining input virus from the cell membranes. At early time
points postinfection, the relative amount of BCBL1-derived
viral DNA present in infected cell lysates was larger than that
of the WT, TW-derived virus (Fig. 3D, upper panel). However,
by 8 days postinfection, relative levels of WT viral DNA in
infected cell lysates were exponentially higher than levels of
BCBL1-derived viral DNA (Fig. 3E, lower panel). LANA expres-
sion decreased more rapidly in BCBL virus-infected cells than in
WT virus-infected cultures over the 96-h period (Table 1).
Visualization of WT KSHV particles on primary epithelial
cell membranes. Enveloped virions formed in cultured cells
infected with the alpha- and betaherpesviruses have been vi-
sualized by high-resolution SEM technology (24, 33, 39). To
determine whether KSHV virions were detected on the mem-
branes of primary oral epithelial cells, we performed SEM on
P-EPI-3 passage 3 monolayers that were endogenously in-
fected or infected with either BCBL1-derived or TW-derived
WT virus. Because of the reported low titers of KSHV in
healthy people, we postulated that this herpesvirus would be
more difficult to detect than other herpesviruses. Surprisingly,
KSHV particles were visualized as easily as other herpesviruses
by SEM (Fig. 4). The virion size was variable, with the majority
of particles having a diameter between 100 and 150 nm, al-
though a few larger particles were also seen (Fig. 4). Consid-
erably more virions were present on the WT and BCBL1 virus-
infected monolayers than on the endogenously infected
monolayers (Fig. 5). The virion surfaces were pleiomorphic in
character, a common finding among herpesviruses, particularly
those considered to be more cell associated. These results
documented the presence of KSHV virions on the surfaces of
endogenously infected primary oral epithelial cells. More im-
portantly, the markedly increased numbers of virions present
on both BCBL1- and WT virus-infected P-EPI membranes
confirmed the fact that viral replication and virion assembly
occurred in these cells.
Inhibition of WT KSHV replication by antiviral compounds
and inhibition of infection by neutralizing antibodies. To fur-
ther confirm WT KSHV replication in epithelial cells and to
rule out detection of contaminating viruses bound to cell sur-
faces, we used the antiviral compounds acyclovir and ganciclo-
vir to block virus replication. At the time of infection, the cells
were cultured in the presence or absence of the antiviral com-
pound. In the presence of 2.5 mg of ganciclovir/ml, K8.1 gly-
coprotein expression was abolished in P-EPI-2 cells by 24 hpi
(Fig. 6A). As expected, expression of the LANA antigen was
not affected by the presence of ganciclovir (data not shown).
Furthermore, the addition of ganciclovir to the P-EPI-2 cells
blocked the replication of the endogenous KSHV in these cells
(Fig. 6A). Acyclovir has also been shown to decrease KSHV
replication, although it does not completely inhibit the virus
(26). In the presence of 10 mg of acyclovir/ml, WT KSHV K8.1
glycoprotein expression detected at 48 hpi in A293T cells was
reduced by 50%, from 	200 positive foci/well in the absence of
the drug to 100 positive foci/well in the presence of the drug
(data not shown). In addition, the K8.1-positive foci were
smaller (compare foci in Fig. 2D to those in Fig. 6B). In the
presence of acyclovir, the BCBL1-derived virus was reduced
from three foci/well to one barely detectable focus of K8.1
expression (Fig. 6B).
Akula et al. previously demonstrated the efficacy of neutral-
izing antibodies against gB for blocking in vitro KSHV infections
(1). To confirm that the epithelial cells were being infected by the
resuspended WT and BCBL virus pellets, we incubated the virus
pellets with either neutralizing antibodies to KSHV gB or a con-
trol antibody prior to infection. Neutralizing antibodies dramati-
cally decreased the ability of WT and BCBL viruses to infect
T-EPI cells (Fig. 6C). In addition, the infection of A293T cells in
the presence of ganciclovir inhibited WT and BCBL lytic repli-
cation, as demonstrated by the absence of spliced K8.1 cDNA
(Fig. 6D). The results of these inhibition experiments further
substantiated that the WT virus entered and replicated within the
in vitro oral epithelial cell model system.
DISCUSSION
We have shown that WT KSHV is present in the oral cavities
of healthy individuals and that this virus is capable of permis-
FIG. 2. Detection of KSHV in epithelial cell lines infected with WT KSHV. (A) Detection of WT KSHV antigens in MeWo cells. Monolayers
were fixed and incubated with antibodies against KSHV LANA or K8.1 glycoproteins at 24 h postinfection. Secondary antibodies conjugated to
Alexa 488 were used to detect the primary antibody bound to the KSHV protein, and ToPro-3 dye was used to detect the cell nuclei. Upper photos
show the Alexa 488 channel, and lower photos show the Cy5 channel and the ToPro-3-stained nuclei. (B) PCR detection of KSHV ORF 26 DNA
in MeWo cells. Three hundred nanograms of cellular DNA was used as template for the first round PCR, and 5 l of the first round reaction was
use as template DNA for the second round. Lane 1, mock-infected cells; lane 2, 48 hpi BCBL1 virus-infected cells; lane 3, 48 hpi WT virus-infected
cells; lanes 4 and 5, DNA isolated from BCBL1 or BJAB cells that was used as positive and negative controls, respectively; lane 6, no DNA.
(C) Real-time PCR detection of WT KSHV ORF 73 DNA in MeWo cells. Three hundred nanograms of DNA isolated from infected with either
BCBL1 virus or WT TW virus (WT virus) or mock-infected cells and harvested at 16 and 96 h postinfection was used as template for real-time
PCR detection of KSHV ORF 73 DNA. DNA from TPA-activated BCBL1 cells served as a positive control. KSHV DNA copy numbers relative
to a standard curve of 10-fold serially diluted BCBL1 DNA are in parentheses. n. det., not detectable. (D) Detection of WT KSHV antigens in
A293T cells at 24 to 96 hpi. Infected monolayers were fixed and incubated with antibody against KSHV K8.1 glycoprotein. Secondary antibodies
conjugated to AlexaFluor 488 were used to detect the primary antibody bound to the KSHV protein, and ToPro-3 dye was used to detect the cell
nuclei.
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FIG. 3. Detection of WT KSHV infection of primary oral epithelial cells. P-EPI-2 passage 5 (A) and T-EPI 1 passage 10 (B) monolayers were
fixed and incubated with isotype antibody, or antibodies against KSHV LANA or K8.1 glycoprotein at 24, 48, 72, and 98 hpi with virus isolated
from throat wash samples from 4 different donors; one donor used for infections shown in Fig. 3A, and virus isolated from three other donors was
used for panels B to E. Virus isolated from TPA-induced-BCBL1 and uninfected BJAB supernatant (Endog.) were used as positive and negative
controls, respectively. (A) Expression kinetics of latent (LANA) and lytic (K8.1) KSHV antigens in P-EPI cells. Secondary antibodies conjugated
to AlexaFluor 488 were used to detect the primary antibody bound to KSHV antigens, and ToPro-3 dye was used to detect the cell nuclei. Upper
photos in each row show the AlexaFluor 488 channel, and lower photos show the AlexaFluor 488 and ToPro-3 and bright field. Row 1, 48 hpi K8.1
expression (left panels, isotype control); row 2, 48 hpi LANA expression; row 3, 72 hpi K8.1 expression; row 4, 72 hpi LANA expression.
(B) Expression kinetics of latent (LANA) and lytic (K8.1) KSHV antigens in T-EPI cells. Secondary antibodies conjugated to AlexaFluor 488 were
used to detect the primary antibody bound to KSHV antigens, and ToPro-3 dye was used to detect the cell nuclei. Upper photos in each row show
the AlexaFluor 488 channel, and lower photos show the AlexaFluor 488, ToPro-3 and bright field, or AlexaFluor 547 overlay. Row 1, 24 hpi K8.1
expression; row 2, 24 hpi LANA expression; row 3, 96 hpi K8.1 expression; row 4, 96 hpi LANA expression. Secondary antibodies conjugated to
AlexaFluor 488 were used to detect the primary antibody bound to KSHV antigens, and ToPro-3 dye was used to detect the cell nuclei. Upper
photos in each row show the AlexaFluor 488 channel, and lower photos show the AlexaFluor 488, ToPro-3 and bright field, or AlexaFluor 547
overlay. (C) More lytic than latent antigen expression in T-EPI cells. Secondary antibodies conjugated to goat anti-rabbit AlexaFluor 547 (red) or
goat anti-rat or mouse AlexaFluor 488 (green) were used to detect the primary antibody bound to KSHV antigens, and ToPro-3 dye (blue) was
used to detect the cell nuclei. Upper panels show the AlexaFluor 488 and AlexaFluor 547 channels; and lower panels show the AlexaFluor 488,
AlexaFluor 547, and ToPro-3 overlay. Left photos, negative and positive controls in BCBL1 cells. Center photos, faint LANA expression (red),
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sive infections of oral epithelial cells. The present data dem-
onstrate for the first time that normal human oral epithelial
cells can be productively infected by KSHV in vivo and are
capable of infection transfer in vitro. The infection of P-EPI
and T-EPI cells with WT KSHV isolated from healthy individ-
uals resulted in productive viral expression. Additional exper-
iments detected the infection of naïve epithelial cells with
endogenous WT KSHV virions, suggesting that oral epithelial
cells may constitute an infectious reservoir for KSHV, as has
previously been documented for Epstein-Barr virus and mu-
rine homologues (20, 35, 40, 41). In addition, we detected
KHSV virions in buccal cells from healthy TW donors by
transmission electron microscopy and detected both lytic and
latent viral proteins by immunogold labeling (data not shown).
While the early B cell is the principally infected cell type in the
peripheral blood of KSHV-seropositive patients with KS, our
data suggested that the expression of the integrin receptor
might render oral epithelium a cellular portal for KSHV in-
fection via oral mucosal exposure (2, 38).
The data are consistent with previous studies showing infec-
tion of epithelial cells derived from foreskin keratinocytes (3, 9).
Oral epithelial cell types ranging from primary to transformed
were susceptible substrates. The evidence of infection included
the detection of viral gene products, increases in viral DNA in
infected cell lysates over time, and drug inhibition studies, all of
which were indicative of productive infections in vitro.
Previous studies have shown that it is difficult to sustain
rounds of serial KSHV passaging. Increasing amounts of lytic
protein expression and the increased quantities of viral DNA
over time subsequent to infection of oral epithelial cells and
A293T cells with WT virus demonstrated productive infections
in vitro rather than lingering input virus (Fig. 2 and 3). In
addition, the virus from endogenously infected lower passage
P-EPI cells could be isolated from the culture medium and
used to infect higher passage T-EPI cells from which the virus
had been lost (data not shown).
Similar to the case with other gammaherpesviruses, the ex-
pression of viral gene products in oral epithelial cells suggests
that the oral mucosa may represent the predominant reservoir
of infectious virus for KSHV transmission. Mucosal epithelial
sites are frequently the site of lytic gammaherpesviral infec-
tions, as determined by infection of murine lung epithelial cells
and gastric epithelial cells with murine herpesvirus 68 (35, 41).
The AIDS-associated oral hairy leukoplakia lesion, the only
cytoplasmic K8.1 (red) expression, and DNA (blue) in T-EPI cells 38 hpi with WT KSHV. Right photos, cytoplasmic gB (red) and perinuclear
LANA expression (green). (D) Detection of K8.1 cDNA in P-EPI cells. cDNA generated from RNA isolated from 105 PEPI cells at 96 hpi was
used as template for real-time PCR amplification of a 161-bp region of the K8.1 gene containing a 94-bp splice (19). The PCR was electrophoresed
on a 2% agarose gel. A 32P-labeled oligonucleotide probe internal to the primer pair was hybridized to the amplification products after Southern
blot transfer. Induced BCBL1 cells served as positive controls. Duplicate cDNA samples generated with (RT lanes; 161-bp product from spliced
template) and without added reverse transcriptase (RT lanes; 255-bp product from unspliced template) served as controls to detect genomic
DNA. (E) Real-time PCR detection of KSHV DNA in passage 7 T-EPI 1-infected cells. DNA was isolated from cells infected with BCBL virus
or WT TW virus (WT) or mock infected. Cells harvested at 2 days postinfection (top panel) or after 1 passage at 8 days postinfection (bottom
panel) were used as templates for real-time PCR detection of KSHV ORF 73 DNA. DNA from TPA-activated BCBL1 cells served as a positive
control (upper panel). Endog, DNA from an untreated low passage T-EPI cell monolayer containing endogenous virus. KSHV DNA copy numbers
relative to a standard curve of 10-fold serially diluted BCBL1 DNA are in parentheses. n. det., not detectable.
FIG. 4. Representative scanning electron micrograph of KSHV
virions (blue or white) at 40,000 magnification on infected P-EPI
cells (epithelial cell plasma membrane extensions shown in green).
P-EPI cells infected with either WT or BCBL1 KSHV were cultured
for 48 h prior to processing.
FIG. 5. SEM detection of KSHV virions on P-EPI cell membranes.
Endogenously infected P-EPI-3 passage 3 cells (E and F) were infected
with WT KSHV (C and D) or control BCBL1 (A and B) virus and
cultured for 48 h prior to processing. Magnification: 15,000 for pan-
els A, C, and E; 5,000 for panels B, D, and F.
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pathological manifestation of permissive Epstein-Barr virus
infection, exhibits abundant viral replication within oral epi-
thelial cells (45). The oral cavity is also a reservoir for Epstein-
Barr virus infection in healthy individuals (40, 43). Other her-
pesviruses, such as HHV-6 and HHV-7, are also present in the
oral cavity. However, the presence of these viruses was not
examined in this study. The present data documented low but
detectable levels of KSHV in primary oral epithelial cell cul-
tures (Fig. 1 and 4). However, the endogenous virus present in
these primary cells could be induced to replicate. We have
shown that P-EPI and T-EPI cells were readily infectable, with
apparent replication differences depending on whether the
source of the virus was the WT from immunocompetent indi-
viduals or laboratory-adapted BCBL1-derived virus (Fig. 2 and
3). Oral epithelial cells more readily sustained infection by WT
isolates than by BCBL1-derived virus, revealing potential dif-
ferences in pathogenicity.
The scanning electron micrographs confirmed that numer-
ous viral particles are present on the surfaces of P-EPI cells
(Fig. 4 and 5). When viewed at a lower magnification, HSV-1
emerges uniformly over the infected cell surface (33, 39),
whereas varicella-zoster virus (VZV) often emerges in a pat-
tern called viral highways (24, 33). KSHV emerged in clusters,
with larger numbers of particles at the leading edge of an
infectious focus. Although differences in the egress patterns
may appear subtle after a cursory examination, the inspection
of hundreds of micrographs has defined distinguishing features
for each of the human herpesviruses. When the surfaces of the
different herpesvirus particles were compared at higher mag-
nifications (	40,000), HSV-1 was the most prototypic
whereas VZV was the most pleiomorphic, with only a small
fraction of surface virions having a prototypic appearance.
HSV-2 was more pleiomorphic than HSV-1 but less than VZV.
In turn, KSHV fell between HSV-2 and VZV. Based on the
above SEM observations, increased pleiomophism correlates
with the property of increased cell-associated nature of growth
in cell culture. To the extent that P-EPIs can sustain low levels
of productive infection, these cells may provide a foothold for
KSHV in the body and subsequently transfer infection to more
productive cell types, such as B lymphocytes trafficking through
the oral mucosa, in which latency may be established, and
endothelial cells during KS development. Consistent with this
hypothesis, we recently observed the in vitro transfer of infec-
tion from KSHV-infected T-EPI to tonsillar lymphocytes (Fig.
g of anti-gB or negative control UK218 antibody/ml for 1 h prior to
infection of T-EPI or A293T cells. At 96 hpi, cells were processed for
IFA. Photos show the Alexa 488 and ToPro-3 overlay. (D) Ganciclovir-
mediated inhibition of lytic gene expression in A293T cells. A293T
cells were infected in the presence or absence of 2.5-mg/ml ganciclovir
( GAC) for 24 h (upper panel) or 72 h (lower panel). cDNA with or
without reverse transcriptase (RT) was generated from isolated
RNA and used as template for real-time PCR amplification of a region
of the K8.1 gene containing a 94-bp splice (19). The PCR was elec-
trophoresed on a 2% agarose gel. A 32P-labeled oligonucleotide probe
internal to the primer pair was hybridized to the amplification products
after Southern blot transfer. Induced BCBL1 cells served as positive
controls. Duplicate cDNA samples generated with (RT lanes; 161-bp
product from spliced template) and without added reverse transcrip-
tase (RT lanes; 255-bp product from unspliced template) served as
controls to detect genomic DNA.
FIG. 6. Inhibition of WT KSHV replication or infection in epithe-
lial cells. (A) Inhibition of lytic replication in primary epithelial cells by
ganciclovir. P-EPI-2 passage 5 cells were infected with WT KSHV or
control BCBL1 virus and cultured with or without 2.5 mg of ganciclo-
vir/ml for 24 h prior to IFA detection of glycoprotein K8.1. Left panel,
no ganciclovir; right panel, ganciclovir added. Upper photos show the
Alexa 488 filter, and lower photos show the Alexa 488 and ToPro-3 and
bright-field overlay. (B) Inhibition of WT KSHV lytic replication in
A293T cells by acyclovir. A293T cells were infected in the presence of
10 mg of acyclovir/ml, and examined at 48 hpi. Upper photos show the
Alexa 488 channel, and lower photos show the Alexa 488, ToPro-3 and
bright-field overlay. (C) Inhibition of WT KSHV infectivity by neu-
tralizing antibody against gB. Virus suspension was incubated with 60
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7). Such results are analogous to infection patterns for the
related gammaherpesvirus Epstein-Barr virus and lead us to
propose a model in which virus cycles from epithelial cells to
the lymphoid compartment (Fig. 7).
While evidence of in vitro lytic KSHV infection in the liter-
ature is sparse, it has been described in both endothelial cells
and in the transformed epithelial cell line HEK293 (13, 16, 21,
28). Recently, Bechtel and colleagues (3) demonstrated that
multiple cell lines latently infected with BCBL-derived KSHV
were readily induced to replicate after transduction with an
adenovirus expressing the immediate-early transactivator Rta,
suggesting that lytic KSHV replication is cell type dependent
(4). Abundant KSHV lytic replication was detected at early
time points in P-EPI and T-EPI cells and occurred in the
absence of a detectable latent phase in A293T cells, an SV40-
transformed clone of HEK 293 (Fig. 2). Megakaryon forma-
tion due to infected cell membrane fusion is a phenomenon
commonly associated with lytic herpesvirus infections (20).
KSHV-mediated membrane fusion has been observed in 293
and B cells transiently transfected with gB, gH, and gL glyco-
proteins (36). Megakaryon formation in the absence of detect-
able latency was observed with the WT KSHV infection of the
A293T cell line, but was not detected in cells infected with
BCBL1-derived virus (Fig. 2D), again suggesting a pathogenic
difference between isolates. Similarly, cell-cell fusion was also
observed at later time points in P-EPI and T-EPI monolayers
infected with WT but not BCBL1-derived KSHV (Fig. 3A,
K8.1 – 72 hpi), although the areas of fusion were not as exten-
sive as those observed in the transformed cell lines. These
results were consistent with those of Pertel (36) and suggested
that WT KSHV is able to mediate cell fusion in vitro. Taken
together with the observed replication kinetics, these data
point to differences between WT KSHV and laboratory-
adapted, PEL-derived viruses that have been employed in the
majority of previous studies.
In conclusion, we have shown that KSHV is harbored in the
oral cavity of healthy individuals and that this virus is capable
of permissive infection in oral epithelial cells. To our knowl-
edge, these studies provide the first direct comparison of in
vitro infection of WT KSHV from the oropharynx of healthy
individuals to PEL-derived, lab-adapted virus. In the absence
of severe immunosuppression, the infection may persist at a
low level for the lifetime of the host, being controlled by the
intact immune response. Further studies will help us to identify
factors that influence the vulnerability of oral epithelial cells to
KSHV infection and to more fully define their role in convey-
ing infection to lymphocytes.
FIG. 7. Model of KSHV infection and reactivation in the oral cavity of immunocompetent individuals. Lytic replication in the oral epithelium
may serve as a reservoir of infectious virus. (A) K8.1-positive oral epithelial cell. Virus from this reservoir may then infect trafficking lymphocytes
and lymphoid tissue in the oropharynx, replicate and then establish latency. (B) K8.1-positive tonsil cell 24 hpi with TW-derived virus. This may
in turn provide a latent virus reservoir. Purple circles in nuclei represent latently infected cells.
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